Sweeping job cuts and reorganizations taking place at the US Department of Health and Human Services under Secretary Robert F ...
Massive cuts at the FDA have hit staff tied to drug reviews and user fees, putting future approvals in jeopardy, according to multiple reports.
1d
HealthDay on MSNFDA Delays Final Approval of Novavax COVID VaccineKey Takeaways The U.S. Food and Drug Administration has delayed full approval of Novavax's COVID vaccineThe agency says it needs more data before making a final decisionNovavax says its vaccine is ...
More top vaccine regulators at the FDA have either left or been forced out, which could hobble the agency's ability to ...
The FDA was supposed to make a final decision about approval of Novavax's COVID-19 vaccine this week, but that deadline has ...
Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...
Ex-vaccine regulator Peter Marks promoted "ineffective therapy that gave patients false hope, eroded trust in the regulatory ...
Novavax's COVID-19 vaccine received FDA Emergency Use Authorization, but full approval faces delays as regulators request more data beyond the April 1 deadline.
Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon ...
The live vaccine is produced from the strain Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN), an attenuated, non-replicating orthopoxvirus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results